INVESTMENT WITH AFFILIATES, AVAILABLE FOR SALE EQUITY SECURITIES	6 Months Ended
Jun. 30, 2011
INVESTMENT WITH AFFILIATES, AVAILABLE FOR SALE EQUITY SECURITIES	4. INVESTMENT WITH AFFILIATES, AVAILABLE FOR SALE EQUITY SECURITIES All of the Company’s available-for-sale equity securities are shares of Chimera and CreXus and are reported at fair value. The Company owned approximately 45.0 million shares of Chimera at a fair value of approximately $155.6 million at June 30, 2011 and approximately 45.0 million shares of Chimera at a fair value of approximately $184.9 million at December 31, 2010. At June 30, 2011, the investment in Chimera had an unrealized gain of $16.8 million. On March 29, 2011, the Company acquired an additional 5.0 million shares of CreXus, which settled on April 1, 2011 . The Company owned approximately 9.5 million shares of CreXus at a fair value of approximately $105.9 million at June 30, 2011 and approximately 4.5 million shares of CreXus at a fair value of approximately $59.3 million at December 31, 2010. At June 30, 2011, the investment in CreXus had an unrealized loss of $19.6 million.

INVESTMENT WITH AFFILIATES, AVAILABLE FOR SALE EQUITY SECURITIES

6 Months Ended

Jun. 30, 2011

INVESTMENT WITH AFFILIATES, AVAILABLE FOR SALE EQUITY SECURITIES

4. INVESTMENT WITH AFFILIATES, AVAILABLE FOR SALE EQUITY SECURITIES

All of the Company’s available-for-sale equity securities are shares of Chimera and CreXus and are reported at fair value. The Company owned approximately 45.0 million shares of Chimera at a fair value of approximately $155.6 million at June 30, 2011 and approximately 45.0 million shares of Chimera at a fair value of approximately $184.9 million at December 31, 2010. At June 30, 2011, the investment in Chimera had an unrealized gain of $16.8 million.

On March 29, 2011, the Company acquired an additional 5.0 million shares of CreXus, which settled on April 1, 2011 . The Company owned approximately 9.5 million shares of CreXus at a fair value of approximately $105.9 million at June 30, 2011 and approximately 4.5 million shares of CreXus at a fair value of approximately $59.3 million at December 31, 2010. At June 30, 2011, the investment in CreXus had an unrealized loss of $19.6 million.